There are many ways members of the public can participate in
research, from focus groups to patient advocacy groups to
volunteering in a clinical study. Participants report feeling more
satisified with their health care and can potentialy gain access to
new treatments avaialble only to research volunteers.
Nikhil Satchidanand, PhD, one of the first KL2 Scholars in the
University at Buffalo Clinical and Translational Science
Award-linked KL2 Mentored Career Development Award (MCDA) program,
has joined the faculty of the Jacobs School of Medicine and
Biomedical Sciences Department of Medicine as an assistant
professor, it was announced in February.
This month UB’s Clinical and Translational Science
Institute (CTSI) welcomed two new scholars to the ranks of the
Buffalo Translational Consortium (BTC) Mentored Career Development
Award (MCDA) program.
Two publications in prestigious, peer-reviewed journals which
explore treatments for substance use disorders were selected as
winners of the Buffalo Translational Consortium 2017 Clinical
Research Achievement Awards.
The CTSI Statistical Workshop Series, which began in September
and continues through May, includes the following core
competencies: statistical approaches, study design, sources of
error, research questions and literature critique.
Margarita L. Dubocovich, PhD, director of the UB CTSI Workforce
Development core and the program lead and principle investigator of
the CTSI’s KL2 program, has been awarded the inaugural
Dolores Shockley Minority Mentoring Award from the American College
of Neuropsychopharmacology (ACNP).
If you’ve ever visited the fifth-floor atrium of the
Clinical and Translational Research Center (CTRC), odds are
you’ve noticed a large pine tree growing in the corner over
by the north-facing windows.
The CTSI Workforce Development Core, Community Engagement Core
and the KL2 Mentored Career Development Program are pleased to
announce the Clinical and Translational Research Core Competencies
on Community Engagement.
Starting January 25, 2018, NIH-defined clinical trial
applications must be submitted using a Funding Opportunity
Announcement (FOA) that is worded specifically for clinical
trials. In the past, clinical trial applications could be submitted
for FOAs that were not identified as being clinical-trial specific.
Submitting to the wrong FOA will lead to rejection of your
An enthusiastic crowd of at least 175 local trick-or-treaters
and their families turned out for the first-ever “Tricks,
Treats and Discoveries: Family Fun and Learning Fair,” held
October 28 in the Educational Opportunity Center on the Buffalo
Niagara Medical Campus (BNMC).
The UB Clinical Research Office announced that effective Monday,
November 13, 2017, two new initiatives to facilitate and
support clinical research across UB will be initiated:
Central Study Registration (CSR) and Department/School Scientific
One of the main goals of UB’s Clinical and Translational
Science Institute (CTSI) is to advance clinical and translational
research that will improve the health and well-being of people
living in Western New York, with a special emphasis on reducing the
health disparities experienced by many in our community, including
underrepresented minority groups and the poor.
James Marks, MD, MPH, a 1973 graduate of UB’s medical
school and executive vice president at the Princeton-based Robert
Wood Johnson Foundation, returned home during Alumni Weekend in
October to talk about the economic impact that academic medical
centers can have on a city like Buffalo.
An important goal of UB’s Clinical and Translational
Science Institute (CTSI) is to improve the representativeness of
research studies, including participants from special populations
such as children, the elderly, underrepresented racial and ethnic
groups, and people with disabilities.
The Fall Seminar Series at the University at Buffalo Research
Institute on Addictions will feature national experts on heavy
drinking in young adults, dating violence, financing addiction
treatment and tobacco use.
An article in Health about a report from the Los Angeles
coroner’s office that found that actress Carrie Fisher had
multiple drugs in her system when she died after suffering a heart
attack in December. The story features an extensive interview with
Kenneth Leonard, who is the director of UB’s Research
Institute on Addictions and a CTSI board member.
UB’s ongoing efforts to recruit underrepresented students
in science, technology, engineering and mathematics (STEM) to its
PhD programs have received a major boost from the National
Institutes of Health, which renewed a five-year, $2.3 million grant
to help fully fund scholarships.
BUFFALO, N.Y. – Rina Das Eiden, PhD, senior research
scientist in the University at Buffalo’s Research Institute
on Addictions, and a Buffalo Translational Consortium partner, has
been named chair of the Psychosocial Development, Risk and
Prevention Study Section in the National Institute of
Health’s Center for Scientific Review.
L. Nelson “Nick” Hopkins is a pioneer in the use of
catheters — long, flexible tubes — inserted into the
vascular system in the groin and threaded to the brain to treat
strokes. The procedure, once called “crazy” by the
medical establishment, is now the preferred method in many
Margarita L. Dubocovich, PhD, SUNY Distinguished Professor of
pharmacology and toxicology has been awarded the UB
President’s Medal, which recognizes “truly
extraordinary effort on behalf the university and the communities
we serve,” according to University at Buffalo President
Satish K. Tripathi, PhD.
A National Institutes of Health (NIH) training grant aimed at
providing professional development resources and mentoring for
doctoral students in several UB schools has been renewed for
another five years.
More than 20 UB faculty and staff members were on hand to
represent the Clinical and Translational Science Institute (CTSI)
at the Translational Science 2017 conference held in Washington,
D.C., April 19-21.
The University at Buffalo Jacobs School of Medicine and
Biomedical Sciences welcomed a scientific celebrity to campus for
the Clinical and Translational Science Institute (CTSI) Seminar
Series/O.P. Jones Lecture on May 2.
Four Western New York medical practitioners were honored on
April 28 by the Jacobs School of Medicine and Biomedical Sciences
at the University at Buffalo, including two faculty members
associated with the UB Clinical and Translational Science Institute
The University at Buffalo Clinical and Translational Science
Institute (CTSI) Science Seminar Series is pleased to present
renowned biophysicist and professor of structural biology Michael
Levitt for the 2017 O.P. Jones Lecture entitled, “The Birth
and Future of Multiscale Modeling of Macromolecules.”
The theme of the University at Buffalo School of Nursing 2017
Research Day, held on March 31, was opioid addiction treatment and
prevention, a public health problem that continues to plague
Western New York and many communities throughout the nation.
The main objective of the University at Buffalo Clinical and
Translational Science Institute (CTSI) Drug Development Core is to
foster innovation in drug development and clinical therapeutics
An illustrious researcher in the field of infectious disease
epidemiology was the guest speaker at the inaugural Clinical and
Translational Science Institute 2017 Seminar Series on Feb. 10 in
Farber Hall on UB’s South Campus. A standing-room-only crowd
in the 105-seat lecture hall welcomed Arnold S. Monto, MD, to town
for the seminar, co-sponsored by the UB School of Public Health and
Health Professions and the CTSI.
Reproducible research, in which statistical programming and
documentation is sufficient so that others may replicate results
and the research process, is gaining widespread practice in
biostatistics and many other areas of science.
Clinical research teams in the Buffalo Translational Consortium
(BTC) have a powerful new tool for accessing the de-identified
electronic health records (EHRs) of some 700,000 UBMD patients.
(UBMD is the practice plan of UB’s Jacobs School of Medicine
and Biomedical Sciences.) Created by UB’s Institute for
Healthcare Informatics (IHI), with the support of the Clinical and
Translational Science Award (CTSA), a new desktop dashboard
connects investigators to the massive i2b2 (Informatics for Integrating
Biology and the Bedside) database from the convenience of their
All publications, press releases and other documents that result
from the use of any University at Buffalo Clinical and
Translational Science Award (CTSA) resources are required by the
National Institutes of Health (NIH) to credit the CTSA
If you’re asking a primary care provider to partner in
your research, says 2016 UNYTE Scientific Session keynote speaker
Chester Fox, MD, then you need to remember the buffet line analogy:
You’re asking someone to add an apple to a plate that’s
most likely already full, which means something else is going to
have to come off. And that can be asking a lot.
Which costs are considered “direct” and which are
“indirect” according to the most common federal grant
programs? What are the reporting requirements for modular versus
itemized budgets? Can you include allowances for travel,
conferences, postage or publishing costs in your budget?
The Clinical and Translational Science Award (CTSA) service
cores that provide clinical and translational research support to
investigative teams across the Buffalo Translational Consortium
(BTC) decided to take their show “on the road” this
year, to visit the health sciences research faculty of the
University at Buffalo and its BTC partner institutions on their
All six recipients of the 2014-15
Translational Pilot Studies Program grants will present results
of their research at a colloquium to be held at the University at
Buffalo Clinical and Translational Research Center (CTRC) on
Thursday, October 13, from 1:30 – 5:00 p.m.
According to NIH guidelines, all researchers who submit an
application, proposal or report to the NIH must include the PMC
reference number (PMCID) when citing applicable papers that they
author or that arise from their NIH-funded research.
The NIH funded T35 training grant entitled “Research in
Infectious Diseases, Microbiology and Immunology for Medical
Students” awarded fellowships for the summer of 2016 to six
first year medical students. The goal of the program is to
introduce research experience to medical students early in their
training with an eye toward training the next generation of
Supported by a combination of funds from the Clinical and
Translational Science Award (CTSA) and institutional support, the
CTSA has awarded 7 teams of researchers pilot studies to support
innovative clinical and translational research projects.
As part of the goal of the UB Clinical and Translational Science
Award (CTSA) Hub to share our special expertise and training
programs with the CTSA consortium, we invited early career
investigators in the CTSA consortium to apply for scholarships to
attend a 3-day Pharmacokinetic-Pharmacodynamic (PK-PD) Modelling
Course conducted by the UB School of Pharmacy and
Pharmaceutical Sciences on May 16-18, 2016 at the Niagara Falls